Unjha Formulations Limited (BOM:531762)
India · Delayed Price · Currency is INR 20.01
-1.47 (-6.84%)
At close: May 7, 2026
Unjha Formulations Market Cap
Unjha Formulations has a market cap or net worth of 96.24 million as of May 7, 2026. Its market cap has decreased by -0.74% in one year.
Market Cap
96.24M
Enterprise Value
80.23M
Revenue
148.12M
Ranking
n/a
PE Ratio
9.21
Stock Price
20.01
Market Cap Chart
Since May 25, 2005, Unjha Formulations's market cap has increased from 51.62M to 96.24M, an increase of 86.46%. That is a compound annual growth rate of 3.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 96.24M | -14.08% |
| Dec 31, 2025 | 112.01M | -17.68% |
| Dec 31, 2024 | 136.07M | 86.43% |
| Dec 29, 2023 | 72.99M | 6.19% |
| Dec 30, 2022 | 68.73M | 42.04% |
| Dec 31, 2021 | 48.39M | 19.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 141.11M |
| Desh Rakshak Aushdhalaya | 134.59M |
| Emmessar Biotech & Nutrition | 127.40M |
| Colinz Laboratories | 121.67M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 114.00M |
| Parmax Pharma | 112.31M |
| Beryl Drugs | 110.56M |